|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:mebendazole
|
|
gptkbp:approvedBy
|
1971
|
|
gptkbp:ATCCode
|
P02CA01
|
|
gptkbp:brand
|
gptkb:mebendazole
|
|
gptkbp:contraindication
|
hypersensitivity to mebendazole
pregnancy (use with caution)
|
|
gptkbp:eliminationHalfLife
|
2.5–5.5 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:form
|
gptkb:tablet
oral suspension
chewable tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Vermox
|
|
gptkbp:legalStatus
|
prescription only (in many countries)
|
|
gptkbp:manufacturer
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:mechanismOfAction
|
inhibits microtubule synthesis in worms
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:prescriptionStatus
|
prescription only (in US, UK, Australia)
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
diarrhea
abdominal pain
rash
flatulence
|
|
gptkbp:usedFor
|
treatment of hookworm
treatment of pinworm
treatment of roundworm
treatment of whipworm
treatment of intestinal worm infections
|
|
gptkbp:bfsParent
|
gptkb:mebendazole
|
|
gptkbp:bfsLayer
|
6
|